NEMO1:NEonatal Seizure Using Medication Off-patent (NEMO1)
NEMO1: An Open Label Exploratory Dose Finding and Pharmacokinetic Clinical Trial of Bumetanide for the Treatment of Neonatal Seizure Using Medication Off-patent
Sponsor: Cork University Hospital
This PHASE1/PHASE2 trial investigates Neonatal Seizures and is currently completed. Cork University Hospital leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cork University Hospital
- Erasmus Medical Center
- Great Ormond Street Hospital for Children NHS Foundation Trust
- Helsinki University Central Hospital
- Hôpital Necker-Enfants Malades
- Karolinska University Hospital
- Only For Children Pharmaceuticals
- The Leeds Teaching Hospitals NHS Trust
- UMC Utrecht
- University College London Hospitals
- Uppsala University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .